Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals

Microbiology

Volumn 152, Issue 1, 2006, Pages 143-152

  Shaver, Ciara M ^a   Hauser, Alan R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; IN VITRO STUDY; INTERNALIZATION; MAMMAL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA;

ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE; FEMALE; HUMANS; LEUKOCIDINS; LUNG; MICE; MICE, INBRED BALB C; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; PSEUDOMONAS AERUGINOSA;

EID: 30744443237     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.28368-0     Document Type: Article

References (67)

1. Berthelot, P., Attree, I., Plesiat, P., Chabert, J., de Bentzmann, S., Pozzetto, B. & Grattard, F. (2003). Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes. J Infect Dis 188, 512-518.
2. Coburn, J. & Frank, D. (1999). Macrophages and epithelial cells respond differently to the Pseudomonas aeruginosa type III secretion system. Infect Immun 67, 3151-3154.
3. Comolli, J. C., Hauser, A. R., Waite, L., Whitchurch, C. B., Mattick, J. S. & Engel, J. N. (1999). Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect Immun 67, 3625-3630.
4. Cornelis, G. R. (2002). The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol 3, 742-752.
5. Cowell, B. A., Chen, D. Y., Frank, D. W., Vallis, A. J. & Fleiszig, S. M. J. (2000). ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect Immun 68, 403-406.
6. Evans, D. J., Frank, D. W., Finck-Barbancon, V., Wu, C. & Fleiszig, S. M. (1998). Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun 66, 1453-1459.
7. Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L. & Hauser, A. R. (2001). Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147, 2659-2669.
8. Finck-Barbançon, V. & Frank, D. W. (2001). Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU. J Bacteriol 183, 4330-4344.
9. Finck-Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener-Kronish, J. P., Fleiszig, S. M. J., Wu, C., Mende-Mueller, L. & Frank, D. (1997). ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25, 547-557.
10. Fleiszig, S. M. J., Wiener-Kronish, J. P., Miyazaki, H., Vallas, V., Mostov, K., Kanada, D., Sawa, T., Yen, T. S. B. & Frank, D. (1997). Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65, 579-586.
11. Frank, D. W. (1997). The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 26, 621-629.
12. Fraylick, J. E., La Rocque, J. R., Vincent, T. S. & Olson, J. C. (2001). Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function. Infect Immun 69, 5318-5328.
13. Frithz-Lindsten, E., Du, Y., Rosqvist, R. & Forsberg, A. (1997). Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol 25, 1125-1139.
14. Fu, Y. & Galan, J. E. (1999). A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401, 293-297.
15. Garrity-Ryan, L., Kazmierczak, B., Kowal, R., Comolli, J., Hauser, A. & Engel, J. N. (2000). The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect Immun 68, 7100-7113.
16. Goehring, U.-M., Schmidt, G., Pederson, K. J., Aktories, K. & Barbieri, J. T. (1999). The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 274, 36369-36372.
17. Grosdent, N., Maridonneau-Parini, I., Sory, M. P. & Cornelis, G. R. (2002). Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 70, 4165-4176.
18. Guiney, D. G. & Lesnick, M. (2005). Targeting of the actin cytoskeleton during infection by Salmonella strains. Clin Immunol 114, 248-255.
19. Ha, U. & Jin, S. (2001). Growth phase-dependent invasion of Pseudomonas aeruginosa and its survival with HeLa cells. Infect Immun 69, 4398-4406.
20. Hardt, W. D., Chen, L. M., Schuebel, K. E., Bustelo, X. R. & Galan, J. E. (1998). Salmonella typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93, 815-826.
21. Hauser, A. R. & Engel, J. N. (1999). Pseudomonas aeruginosa induces type III secretion-mediated apoptosis of macrophages and epithelial cells. Infect Immun 67, 5530-5537.
22. Hauser, A. R., Kang, P. J. & Engel, J. (1998a). PepA, a novel secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol Microbiol 27, 807-818.
23. Hauser, A. R., Kang, P. J., Fleiszig, S. J. M., Mostov, K. & Engel, J. (1998b). Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect Immun 66, 1413-1420.
24. Hauser, A. R., Cobb, E., Bodi, M., Mariscal, D., Vallés, J., Engel, J. N. & Rello, J. (2002). Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30, 521-528.
25. Henriksson, M. L., Rosqvist, R., Telepnev, M., Wolf-Watz, H. & Hallberg, B. (2000). Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras. Biochem J 347, 217-222.
26. Henriksson, M. L., Sundin, C., Jansson, A. L., Forsberg, A., Palmer, R. H. & Hallberg, B. (2002). Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo. Biochem J 367, 617-628.
27. Holder, I. A., Neely, A. N. & Frank, D. W. (2001). Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns. Burns 27, 129-130.
28. Ichikawa, J. K., English, S. B., Wolfgang, M. C., Jackson, R., Butte, A. J. & Lory, S. (2005). Genome-wide analysis of host responses to the Pseudomonas aeruginosa type III secretion system yields synergistic effects. Cell Microbiol 7, 1635-1646.
29. Jain, M., Ramirez, D., Seshadri, R. & 7 other authors (2004). Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 42, 5229-5237.
30. Kaufman, M. R., Jia, J., Zeng, L., Ha, U., Chow, M. & Jin, S. (2000). Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of ExoS. Microbiology 146, 2531-2541.
31. Krall, R., Schmidt, G., Aktories, K. & Barbieri, J. T. (2000). Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun 68, 6066-6068.
32. Krall, R., Sun, J., Pederson, K. J. & Barbieri, J. T. (2002). In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect Immun 70, 360-367.
33. Lee, V. T., Smith, R. S., Tummler, B. & Lory, S. (2005). Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 73, 1695-1705.
34. Lomholt, J. A., Poulsen, K. & Kilian, M. (2001). Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun 69, 6284-6295.
35. McGuffie, E. M., Fraylick, J. E., Hazen-Martin, D. J., Vincent, T. S. & Olson, J. C. (1999). Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S. Infect Immun 67, 3494-3503.
36. Miyata, S., Casey, M., Frank, D. W., Ausubel, F. M. & Drenkard, E. (2003). Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun 71, 2404-2413.
37. Nicas, T. I. & Iglewski, B. H. (1984). Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect Immun 45, 470-474.
38. Olson, J. C., McGuffie, E. M. & Frank, D. W. (1997). Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect Immun 65, 248-256.
39. Olson, J. C., Fraylick, J. E., McGuffie, E. M., Dolan, K. M., Yahr, T. L., Frank, D. W. & Vincent, T. S. (1999). Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun 67, 2847-2854.
40. Pankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P. & Sawa, T. (2004). Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU. Crit Care Med 32, 2293-2299.
41. Pederson, K. J. & Barbieri, J. T. (1998). Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas aeruginosa exoenzyme S is cytotoxic to eukaryotic cells. Mol Microbiol 30, 751-759.
42. Pederson, K. J., Vallis, A. J., Aktories, K., Frank, D. W. & Barbieri, J. T. (1999). The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Mol Microbiol 32, 393-401.
43. Phillips, R. M., Six, D. A., Dennis, E. A. & Ghosh, P. (2003). In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem 278, 41326-41332.
44. Pukatzki, S., Kessin, R. H. & Mekalanos, J. J. (2002). The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci U S A 99, 3159-3164.
45. Rabin, S. D. P. & Hauser, A. R. (2003). Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae. Infect Immun 71, 4144-4150.
46. Rabin, S. D. P. & Hauser, A. R. (2005). Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun 73, 573-582.
47. Raffatellu, M., Wilson, R. P., Chessa, D., Andrews-Polymenis, H., Tran, Q. T., Lawhon, S., Khare, S., Adams, L. G. & Baumler, A. J. (2005). SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun 73, 146-154.
48. Reed, L. & Muench, J. (1938). A simple method for estimating fifty percent endpoints. Am J Hyg 27, 493-497.
49. Rhame, F. S. (1979). The ecology and epidemiology of Pseudomonas aeruginosa. In Pseudomonas aeruginosa: the Organism, Diseases it Causes, and their Treatment, pp. 31-51. Edited by L. D. Sabath. Bern: Hans Huber Publishers.
50. Rocha, C. L., Coburn, J., Rucks, E. A. & Olson, J. C. (2003). Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect Immun 71, 5296-5305.
51. Roy-Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W. & Wiener-Kronish, J. P. (2001). Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 183, 1767-1774.
52. Sato, H. & Frank, D. W. (2004). ExoU is a potent intracellular phospholipase. Mol Microbiol 53, 1279-1290.
53. Sato, H., Frank, D. W., Hillard, C. J. & 9 other authors (2003). The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 22, 2959-2969.
54. Sawa, T., Ohara, M., Kurahashi, K., Twining, S. S., Frank, D., Doroques, D. B., Long, T., Gropper, M. A. & Wiener-Kronish, J. P. (1998). In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 66, 3242-3249.
55. Schulert, G. S., Feltman, H., Rabin, S. D. P., Martin, C. G., Battle, S. E., Rello, J. & Hauser, A. R. (2003). Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J Infect Dis 188, 1695-1706.
56. Shaver, C. M. & Hauser, A. R. (2004). Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 72, 6969-6977.
57. Sun, J. & Barbieri, J. T. (2003). Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J Biol Chem 278, 32794-32800.
58. Tamura, M., Ajayi, T., Allmond, L. R., Moriyama, K., Wiener-Kronish, J. P. & Sawa, T. (2004). Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU. Biochem Biophys Res Commun 316, 323-331.
59. Tran Van Nhieu, G., Bourdet-Sicard, R., Dumenil, G., Blocker, A. & Sansonetti, P. J. (2000). Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell Microbiol 2, 187-193.
60. Vallis, A. J., Finck-Barbancon, V., Yahr, T. L. & Frank, D. W. (1999). Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67, 2040-2044.
61. Vance, R. E., Rietsch, A. & Mekalanos, J. J. (2005). Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 73, 1706-1713.
62. Vincent, T. S., Fraylick, J. E., McGuffie, E. M. & Olson, J. C. (1999). ADP-ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo. Mol Microbiol 32, 1054-1064.
63. Vogel, H. J. & Bonner, D. M. (1956). Acetylornithinase of Escherichia coli partial purification and some properties. J Biol Chem 218, 97-106.
64. Yahr, T. L., Vallis, A. J., Hancock, M. K., Barbieri, J. T. & Frank, D. W. (1998). ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A 95, 13899-13904.
65. Zhou, D., Mooseker, M. S. & Galan, J. E. (1999a). An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc Natl Acad Sci U S A 96, 10176-10181.
66. Zhou, D., Mooseker, M. S. & Galan, J. E. (1999b). Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 283, 2092-2095.
67. Zhou, D., Chen, L. M., Hernandez, L., Shears, S. B. & Galan, J. E. (2001). A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 39, 248-259.